Emmanuel Archavlis

Statistics

Publications

Citations

401

H-Index

Active since

2002

Affiliations

Evangelismos Hospital(Current)

Emmanuel Archavlis is an author at Evangelismos Hospital specializing in gastrointestinal pharmacotherapy, inflammatory bowel disease, and gastroenterology.

Publications per year

2002–2015

Publications

A Prospective Randomized Observer-Blind 2-Year Trial of Azathioprine Monotherapy versus Azathioprine and Olsalazine for the Maintenance of Remission of Steroid-Dependent Ulcerative Colitis

Gerassimos J. Mantzaris, Michael Sfakianakis, Emmanuel Archavlis et al. · The American Journal of Gastroenterology · 2004 · 125 citations

Pharmacy, Pharmacotherapy, Bowel Management +16

Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: A prospective, two-year, single center, pilot study

Konstantinos Papamichael, Emmanuel Archavlis, Constantina Lariou et al. · Journal of Crohn s and Colitis · 2012 · 108 citations · Full text

Medicine, Immunology, Surgery +14

Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection

Gerassimos J. Mantzaris, Kalliopi Petraki, Emmanuel Archavlis et al. · European Journal of Gastroenterology & Hepatology · 2002 · 64 citations

Medicine, Pharmacology, Pharmacotherapy +16

Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn’s Disease Recurrence

Marc Ferrante, Konstantinos Papamichael, Dana Ďuricová et al. · Journal of Crohn s and Colitis · 2015 · 50 citations · Full text

Medicine, Clinical Sciences, Surgery +16

Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease

Gerassimos J. Mantzaris, Kalliopi Petraki, Michael Sfakianakis et al. · Clinical Gastroenterology and Hepatology · 2003 · 39 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

1–5 of 6